Pharmaceutical Contract Manufacturing Industry M&A Implications and Outlook Report 2021: Objectives, M&A Activity 2018-2020, Target Characteristics, Acquirer Characteristics, Geography, Top Acquirers
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition" report has been added to ResearchAndMarkets.com's offering.
This report is the third edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry.
This report gives important, expert insight you won't find in any other source. 28 tables and figures throughout the report illustrate major points and trends.
Scope
This report is required reading for:
CMOs: market trends, strategic planning, competitive intelligence, performance benchmarking
Bio/Pharma: supplier performance benchmarking, market trends, competitive intelligence
Private equity and Stock analysts: target identification and analysis, portfolio company performance benchmarking
Reasons to Buy
Overview of M&A in the Pharma CMO Industry
Detailed view of CDMO performance by number of deals completed from the publisher's Deals database
Analysis of the M&A of specific manufacturing services
Key Topics Covered:
Executive Summary
Players
Trends
Industry Analysis
Objectives and Methodology
Overview of M&A Activity 2018-2020
Target Characteristics
Acquirer Characteristics
Geography
Top Acquirers
Segment Close-Ups of M&A Activity, 2018-2020
API-Biologic
API-Small Molecule
Commercial Dose Manufacturing
Analytical Services
Packaging
Deal Advisors
Top Financial Advisors
Top Legal Advisors
Valuations
Facility Acquisitions
What It Means
The Outlook for M&A
API-Biologic Targets
Past Predictions
Value Chain
Companies
Appendix
For more information about this report visit https://www.researchandmarkets.com/r/r3o4d6
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900